Press "Enter" to skip to content

Posts tagged as “Recent”

Sutro Biopharma Reports Second Quarter 2019 Financial Results and Recent Business Highlights and Developments – BioSpace

admin 0

Sutro Biopharma Reports Second Quarter 2019 Financial Results and Recent Business Highlights and Developments  BioSpace Published: Aug 14, 2019. STRO-001 Initial Safety Data from an Ongoing Phase 1 Trial in Myeloma…

Forty Seven Inc. Reports Second Quarter 2019 Financial Results and Recent Business Highlights – Yahoo Finance

admin 0

Forty Seven Inc. Reports Second Quarter 2019 Financial Results and Recent Business Highlights  Yahoo Finance Forty Seven Inc. (FTSV), a clinical-stage, immuno-oncology company focused on developing therapies to activate macrophages in…

Gritstone Oncology Reports Second Quarter 2019 Financial Results and Recent Highlights – GlobeNewswire

admin 0

Gritstone Oncology Reports Second Quarter 2019 Financial Results and Recent Highlights  GlobeNewswire EMERYVILLE, Calif., Aug. 12, 2019 (GLOBE NEWSWIRE) — Gritstone Oncology, Inc. (Nasdaq: GRTS), a clinical-stage biotechnology company developing the…

Pet Cancer Therapeutics Market Outlook 2019 Witnessing Enormous Growth with Recent Trends & Demand |Aratana Therapeutics, Inc, AB Science, Boehringer Ingelheim International GmbH, Zenoaq, Zoetis, etc. – Finance Express

admin 0

Pet Cancer Therapeutics Market Outlook 2019 Witnessing Enormous Growth with Recent Trends & Demand |Aratana Therapeutics, Inc, AB Science, Boehringer Ingelheim International GmbH, Zenoaq, Zoetis, etc.  Finance Express The global Pet…

UroGen Pharma Reports Second Quarter 2019 Financial Results and Recent Corporate Developments – Business Wire

admin 0

UroGen Pharma Reports Second Quarter 2019 Financial Results and Recent Corporate Developments  Business Wire UroGen Pharma Ltd. (Nasdaq:URGN), a clinical-stage biopharmaceutical company developing treatments to address unmet needs in uro-oncology, today…

UroGen Pharma Reports Second Quarter 2019 Financial Results and Recent Corporate Developments – BioSpace

admin 0

UroGen Pharma Reports Second Quarter 2019 Financial Results and Recent Corporate Developments  BioSpace NEW YORK–(BUSINESS WIRE)– UroGen Pharma Ltd. (Nasdaq:URGN), a clinical-stage biopharmaceutical company developing treatments to address unmet … “bladder…

Ovarian Cancer Diagnostics Market Recent Trends, In-depth Analysis, Market Size Research Report Forecast up to 2022 – Daily Peace Times

admin 0

Ovarian Cancer Diagnostics Market Recent Trends, In-depth Analysis, Market Size Research Report Forecast up to 2022  Daily Peace Times Ovarian cancer is developed by uncontrollable growth of cells in ovaries. Made…